MAPT and Alzheimer disease: Although the role of ApoE4 in AD onset and progression remains unclear, many studies pointed out that ApoE4 may contribute to AD pathogenesis affecting neuronal structure and function, Aβ production and clearance, tau pathology, and neuroinflammation [40].